1Fry W A,Phillips J L,Menck H R.Ten-years survey of lung cnacer treatment and survival in hospitals in United States:ana tional cancer data base report[J].Cancer,1999,86 (9):1867 -1876.
2Le Chevalier T,Berille J,Zalcberg J R,et al.Overview of docetaxel(Taxotere)/cisplatin combination in non-small cell lung cancer[J].Semin Oncol,1999,26(3 Suppl 11):13-18.
2Y. H. Kim,J. S. Kim,Y. H. Choi,K. H. In,H. S. Park,D. S. Hong,T. J. Jeong,Y. Y. Lee,E. Nam,S. N. Lee,K. S. Lee,H. K. Kim.Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic or unresectable localized non-small-cell lung cancer[J]. International Journal of Clinical Oncology . 2002 (2)
3Kim YH,Kim JS,Choi YH,et al.PhaseⅡstudy of docetaxeland cisplatin combination chemotherapy in metastatic or unresect-able localized non-small cell lung cancer. International Journal of Clinical Oncology . 2002
4Schiller JH,Harrington D,Belani CP,et al.Comparison of four chemotherapy regimens for advanced non-small cell lung cancer. The New England Journal of Medicine . 2002
